N9X Stock Overview

Develops and markets dietary supplements, herbal remedies, and personal care products in the Nordic countries, rest of Europe, North America, and internationally. More details

N9X fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	0/6
Financial Health	3/6
Dividends	0/6

Risk Analysis

Earnings have declined by 62.2% per year over past 5 years

Does not have a meaningful market cap (€93M)

My Notes

Capture your thoughts, links and company narrative

New Nordic Healthbrands AB (publ) Competitors

Mustika Ratu

IDX:MRAT

Rp131.8b

Eng Kah Corporation Berhad

KLSE:ENGKAH

RM 40.2m

Takbo Group Holdings

SEHK:8436

HK$72.8m

Aroma AD

BUL:AROM

лв18.5m

Price History & Performance

Summary of share price highs, lows and changes for New Nordic Healthbrands
Historical stock prices
Current Share Price	SEK 1.26
52 Week High	SEK 1.53
52 Week Low	SEK 1.22
Beta	0.92
1 Month Change	0%
3 Month Change	-6.67%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-9.35%

Recent updates

Shareholder Returns

	N9X	DE Personal Products	DE Market
7D	-0.8%	-1.6%	-2.0%
1Y	n/a	-7.6%	6.8%

Return vs Industry: Insufficient data to determine how N9X performed against the German Personal Products industry.

Return vs Market: Insufficient data to determine how N9X performed against the German Market.

Price Volatility

Is N9X's price volatile compared to industry and market?
N9X volatility
N9X Average Weekly Movement	5.2%
Personal Products Industry Average Movement	3.8%
Market Average Movement	4.9%
10% most volatile stocks in DE Market	11.4%
10% least volatile stocks in DE Market	2.4%

Stable Share Price: N9X has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine N9X's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1990	70	Karl Kristian Jensen	www.newnordic.se

New Nordic Healthbrands AB (publ) develops and markets dietary supplements, herbal remedies, and personal care products in the Nordic countries, rest of Europe, North America, and internationally. The company provides vitality tablets, capsules, and gummy products, including vitamins and minerals, fish oil and Omega-3, and magnesium, as well as for body, sleep and relaxation, menopause, and men health; skincare products comprising dietary supplements, facial care, and body care, as well as assortment products; hair care products, such as hair volume products, dietary supplements, shampoos, conditioners, and other hair care products; and weight loss products. The company sells its products through pharmacies, department stores, health stores, and travel retailers, as well as through online stores.

New Nordic Healthbrands AB (publ) Fundamentals Summary

How do New Nordic Healthbrands's earnings and revenue compare to its market cap?
N9X fundamental statistics
Market cap	€8.09m
Earnings (TTM)	-€1.33m
Revenue (TTM)	€47.27m

0.2x

P/S Ratio

-6.1x

P/E Ratio

Is N9X overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
N9X income statement (TTM)
Revenue	SEK 543.28m
Cost of Revenue	SEK 190.39m
Gross Profit	SEK 352.89m
Other Expenses	SEK 368.24m
Earnings	-SEK 15.34m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 28, 2025

Earnings per share (EPS)	-2.48
Gross Margin	64.96%
Net Profit Margin	-2.82%
Debt/Equity Ratio	46.6%

How did N9X perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/24 20:29
End of Day Share Price	2024/12/23 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

New Nordic Healthbrands AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution

New Nordic Healthbrands DB:N9X Stock Report